OOIR: Observatory of International Research

Papers

(The H4-Index of Cytokine & Growth Factor Reviews is 39. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Editorial Board	271
Corrigendum to “Ferroptosis in immune cells: Implications for tumor immunity and cancer therapy” [Cytokine Growth Factor Rev. 84 (2025) 59–73]	148
Unveiling cytokine charge disparity as a potential mechanism for immune regulation	143
Targeting the metabolism and immune system in pancreatic ductal adenocarcinoma: Insights and future directions	130
Navigating IL-6: From molecular mechanisms to therapeutic breakthroughs	130
COVID-19: From emerging variants to vaccination	119
Editorial Board	117
CDK4/6 inhibition in hormone receptor-positive/HER2-negative breast cancer: Biological and clinical aspects	89
Editorial Board	87
Editorial Board	84
Proteomics analysis of circulating small extracellular vesicles: Focus on the contribution of EVs to tumor metabolism	81
Erratum to “TLR-Based therapeutic strategies for Hepatocellular carcinoma” [Cytokine Growth Factor Rev. Volume 85 2025 Pages 179–189]	80
Metabolic Regulation of cGAS-STING Signaling in the Tumor Microenvironment: Dual Immune Roles and Therapeutic Implications	75
Insights into IL-6/JAK/STAT3 signaling in the tumor microenvironment: Implications for cancer therapy	74
Progranulinopathy: A diverse realm of disorders linked to progranulin imbalances	71
Targeting cytokines: Reshaping the pancreatic tumor microenvironment	68
Natural killers or natural regulators? Dual roles of NK cells in checkpoint immunotherapy	62
Epithelial-to-mesenchymal transition transcription factors: New strategies for mesenchymal tissue regeneration	58
Molecular mechanisms of regulation of IL-1 and its receptors	55
Editorial Board	49
Cytokine symphony: Deciphering the tumor microenvironment and metastatic axis in oral cancer	48
Immuno-metabolic control of the balance between Th17-polarized and regulatory T-cells during HIV infection	48
Novel insights into neuroinflammatory mechanisms in traumatic brain injury: Focus on pattern recognition receptors as therapeutic targets	48
Exogenous drug-induced mouse models of atopic dermatitis	47
TGF-β mediated drug resistance in solid cancer	47

Central role of Galectin-3 at the cross-roads of cardiac inflammation and fibrosis: Implications for heart failure and transplantation	47
Chemokines and chemokine receptors: Insights from human disease and experimental models of helminthiasis	46
The immunodynamics of pulmonary fibrosis	46
Scarless wound healing: Current insights from the perspectives of TGF-β, KGF-1, and KGF-2	43
Immunosuppressive tumor microenvironment and uterine fibroids: Role in collagen synthesis	43
The cGAS-STING pathway: Post-translational modifications and functional implications in diseases	43
Exosomes as a modulator of immune resistance in human cancers	42
Exosomes: Another intercellular lipometabolic communication mediators in digestive system neoplasms?	42
MDSCs might be “Achilles heel” for eradicating CSCs	42
Post COVID-19 pandemic Inflammatory Insights into Cancer: Consequences for immunotherapy	40
Multifaceted role of CD14 in innate immunity and tissue homeostasis	40
The role of neurotransmitter signaling in colorectal cancer progression: Opportunities for drug repurposing	40
Tumor microenvironment, histone modifications, and myeloid-derived suppressor cells	40
Editorial Board	40
Targeting the NLRP3 inflammasome in sepsis: Molecular mechanisms and therapeutic strategies	39
Decoding the roles of heat shock proteins in liver cancer	39